Medical News

RSS

Johns Hopkins Medicine recognized for Environmental Sustainability

Johns Hopkins Medicine was recognized for its efforts to reduce its environmental footprint, winning several sustainability awards...

4 Jun 2015

Dexcom® announces follow App is now available for Android devices

Continuous glucose monitoring is considered the most significant breakthrough in diabetes management in the past 40 years...

4 Jun 2015

Two in one to break cycle of poor diabetes management

Now final-year design student Oscar Daws from Brunel University London has come up with a streamlined device which has been selected for a prestigious exhibition on London’s South Bank and aims to vastly improve patients’ self-management of the disease...

4 Jun 2015

AmpliPhi’s bacteriophage manufacturing facility receives cGMP certification

AmpliPhi’s commissioned its production facility in early 2014 after conducting a comprehensive evaluation of global manufacturing options...

4 Jun 2015

Epsom and St Helier Hospitals extend use of VitalPAC.

Since August last year nurses on Medical wards at have been recording patient observation data on mobile electronic devices such as iPods using a digital solution called VitalPAC Nurse...

4 Jun 2015

Tabletop design offers greater stability, especially for small laboratory tables

The low-profile, high-density CleanBench tops offer superior damping, stiffness, and flatness in an easy-to-clean stainless steel shell and are available with or without tapped holes...

4 Jun 2015

Questionnaire predicts chances of middle-aged people living until 2020

People aged between 40 and 70 years can now answer a set of simple questions to calculate their personalised 5-year mortality risk and what is referred to as an “Ubble age” – the age where the average mortality risk in the population is most similar to the estimated risk...

4 Jun 2015

WuXi AppTec, Fudan University partner for genomics database system

WuXi AppTec today announced a partnership with Fudan University to bring WuXi NextCODE's world-leading population human genomics database system and integrated research and clinical solutions to the Fudan-led Collaborative Innovation Center of Genetics and Development as an enterprise partner.

4 Jun 2015

RELM Wireless signs agreement with AHS to provide P25 800MHz portable and mobile radios

RELM Wireless Corporation today announced that it has entered into an agreement with Alberta Health Services to provide P25 800MHz portable and mobile radios and accessories. The contract is for a base term of one year that commenced on March 12, 2015, with four one-year options.

4 Jun 2015

Cytokinetics, The ALS Association expand partnership to fight against ALS

Cytokinetics, Incorporated and The ALS Association announced an expanded partnership in which the company will provide Gold Level Sponsorship of the National Walks to Defeat ALS as well as Platinum Level Sponsorship for ALS Association Golden West Chapter initiatives.

4 Jun 2015

Rhythm announces initiation of two setmelanotide Phase 2 trials for treatment of PWS, POMC-null obesity

Rhythm announced today the initiation of two Phase 2 clinical trials focused on evaluating the safety and effectiveness of setmelanotide (RM-493), the company's novel melanocortin 4 receptor (MC4R) agonist, for the treatment of Prader-Willi Syndrome (PWS) and POMC-null obesity.

4 Jun 2015

Regulus Therapeutics begins RG-012 Phase I clinical study for treatment of Alport syndrome

Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today that dosing has begun in a first-in-human Phase I clinical study of RG-012, a single stranded, chemically modified oligonucleotide that binds to and inhibits the function of microRNA-21 ("miR-21").

4 Jun 2015

CASI files application with CFDA to conduct ENMD-2076 Phase 2 trial in fibrolamellar carcinoma patients

CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a commercial focus on China, announced today that it has filed an application with China's Food and Drug Administration to conduct a Phase 2 clinical trial in fibrolamellar carcinoma (FLC) patients in China for its proprietary drug candidate, ENMD-2076.

4 Jun 2015

First phase of Amway's new $81 million nutrition manufacturing facility opens in Ada, Michigan

Amway today announced the opening of the first phase of its new $81 million USD nutrition manufacturing facility in Ada, Michigan, USA, near its world headquarters. The 317,000-square-foot facility will house select manufacturing operations for the company's Nutrilite brand of vitamins, minerals and dietary supplements, sold exclusively by Amway Business Owners.

4 Jun 2015

Cyberonics announces results for fourth quarter and fiscal year 2015

Cyberonics, Inc. today announced results for the fourth quarter and fiscal year ended April 24, 2015.

4 Jun 2015

Updated SOGC guidelines include FIBRISTAL as only approved medical treatment for uterine fibroids

The Society for Obstetrics and Gynecology of Canada has issued updated guidelines for the management of uterine fibroids (uterine leiomyomas), which now include the first and only approved medical treatment for uterine fibroids: FIBRISTAL (ulipristal acetate).

4 Jun 2015

Profil Institute for Clinical Research forms strategic partnership with Gubra

Profil Institute for Clinical Research, an clinical research organization (CRO) focused on diabetes, obesity and NAFLD/NASH, announced today a strategic collaboration with Gubra ApS, a metabolic preclinical and drug discovery company, to combine expertise and resources to discover and translate into clinical research novel drug targets, compounds and biomarkers addressing metabolic disease.

4 Jun 2015

Kit Check announces issuance of four meaningful patents by U.S. Patent and Trademark Office

Kit Check, the leader in hospital pharmacy kit processing and medication tracking software, today announced that the United States Patent and Trademark Office has issued the company two meaningful patents, with two additional patents set to issue on June 16, 2015. These awards represent a robust portfolio of intellectual property (IP) related to the Kit Check product.

4 Jun 2015

Egalet announces top-line results from Egalet-002 study in moderate drinkers

Egalet Corporation, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative pain treatments, today announced top-line results from a randomized, four-way crossover alcohol-interaction study in healthy male and female moderate drinkers with Egalet-002, an abuse-deterrent, extended-release, oral oxycodone-based product in development for the management of pain severe enough to require daily, around-the-clock opioid treatment and for which alternative treatments are inadequate.

4 Jun 2015

Experimental Zephyr endobronchial valve provides good result in emphysema patient at UAB

In late March, physicians at the University of Alabama at Birmingham carefully threaded a one-way valve the size of a black-eyed pea into the lower lobe of Dennis Bullock's left lung. Bullock, a 67-year-old emphysema patient, was the fourth person at UAB to receive the experimental Zephyr endobronchial valve.

4 Jun 2015

Medical News

Johns Hopkins Medicine recognized for Environmental Sustainability

Dexcom® announces follow App is now available for Android devices

Two in one to break cycle of poor diabetes management

AmpliPhi’s bacteriophage manufacturing facility receives cGMP certification

Epsom and St Helier Hospitals extend use of VitalPAC.

Tabletop design offers greater stability, especially for small laboratory tables

Questionnaire predicts chances of middle-aged people living until 2020

WuXi AppTec, Fudan University partner for genomics database system

RELM Wireless signs agreement with AHS to provide P25 800MHz portable and mobile radios

Cytokinetics, The ALS Association expand partnership to fight against ALS

Rhythm announces initiation of two setmelanotide Phase 2 trials for treatment of PWS, POMC-null obesity

Regulus Therapeutics begins RG-012 Phase I clinical study for treatment of Alport syndrome

CASI files application with CFDA to conduct ENMD-2076 Phase 2 trial in fibrolamellar carcinoma patients

First phase of Amway's new $81 million nutrition manufacturing facility opens in Ada, Michigan

Cyberonics announces results for fourth quarter and fiscal year 2015

Updated SOGC guidelines include FIBRISTAL as only approved medical treatment for uterine fibroids

Profil Institute for Clinical Research forms strategic partnership with Gubra

Kit Check announces issuance of four meaningful patents by U.S. Patent and Trademark Office

Egalet announces top-line results from Egalet-002 study in moderate drinkers

Experimental Zephyr endobronchial valve provides good result in emphysema patient at UAB

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News